New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental preeclampsia

Authors

Abstract

Experimental Modeling ADMA-like preeclampsia administration to rats was performed by Nnitro-L-arginine methyl ester, from 14 to 20 days of pregnancy. The animals were observed increase in blood pressure, proteinuria, impaired microcirculation in the placenta, the violation of the regulation of vascular tone and destructive changes in the placenta of ischemic origin. Introduction of tetrahydrobiopterin, a selective inhibitor of arginase II of, recombinant erythropoietin, tadalafil, erythromycin, azithromycin, and playback systems polivitaminnomineralnyh distant ischemic preconditioning resulted in a pronounced correction of morphological and functional disorders arise when modeling the experimental preeclampsia. This was reflected in the reduction of blood pressure, reduction of proteinuria, increase of microcirculation in the placenta, the restoration of vasodilator function of blood vessels and prevent destructive phenomena in the placenta compared with a group of untreated animals, increasing the concentration of NO end-metabolites in plasma. These data suggest a pronounced correction of morphological and functional disorders arise when modeling ADMA-like preeclampsia study medication and the prospects for further research to find new drugs have endoteleoprotektivnymi properties for correcting the second half of pregnancy preeclampsia.

Keywords:

ADMA, preeclampsia, endothelial dysfunction, rats, endotelioprotektory

Author Biography

Vladimir Gureev, Belgorod State National Research University

Ph.D. Associate Professor, Department of Pharmacology of the Federal State Autonomous Educational Institution of Higher Education "Belgorod State National Research University" of the Ministry of Education and Science of the Russian Federation, Belgorod, Russia

Downloads

Published

10-08-2016

How to Cite

Gureev V (2016) New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental preeclampsia. Research Results in Pharmacology: 11–27

Issue

Section

Review article